How Epstein-Barr Virus Induces the Reorganization of Cellular Chromatin

被引:8
|
作者
Rosemarie, Quincy [1 ]
Kirschstein, Elijah [1 ]
Sugden, Bill [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA
来源
MBIO | 2023年 / 14卷 / 01期
关键词
Epstein-Barr virus; chromatin reorganization; productive infection; virus-host interactions; DNA-POLYMERASE-ALPHA; CHROMOSOME CONDENSATION; CONSERVED REGION; GEMINIVIRUS INFECTION; GENE-EXPRESSION; HOST-CELL; REPLICATION; ARCHITECTURE; BINDING; PROTEIN;
D O I
10.1128/mbio.02686-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have discovered how Epstein-Barr virus (EBV) induces the reorganization of cellular chromatin (ROCC), in which host chromatin is compacted and marginated within the nucleus, with viral DNA replication occurring in the chromatin-free regions. Five families of DNA viruses induce ROCC: herpesviruses, adenoviruses, parvoviruses, baculoviruses, and geminiviruses. These families infect a variety of hosts, including vertebrates, insects, and plants. They also share several characteristics: they replicate and encapsidate their genomes in the host nucleus and package their genomes unbound by histones. We have identified the viral genes and processes required for EBV's ROCC. Each of EBV's seven core DNA synthesis genes and its origin of lytic replication (oriLyt), in trans, are required, while its protein kinase, BGLF4, and its true late genes are not. Following these findings, we tested the role of EBV lytic DNA amplification in driving ROCC. Surprisingly, the inhibition of EBV's lytic DNA synthesis still supports chromatin compaction but blocks its margination. We propose a two-step model for ROCC. First, the initiation of viral lytic DNA synthesis induces a cellular response that results in global chromatin compaction. Second, the histone-free, productive viral DNA synthesis leads to the margination of compacted chromatin to the nuclear periphery. We have tested this model by asking if the histone-associated simian virus 40 (SV40) DNA synthesis could substitute for oriLyt-mediated synthesis and found that EBV's ROCC is incompatible with SV40 DNA replication. Elucidating EBV's induction of ROCC both illuminates how other viruses can do so and indicates how this spatial control of cellular chromatin benefits them.IMPORTANCE Five families of viruses support the reorganization of cellular chromatin (ROCC), the compaction and margination of host chromatin, upon their productive infection. That they all share this phenotype implies the importance of ROCC in viral life cycles. With Epstein-Barr virus (EBV), a herpesvirus, we show that the viral replication complex and origin of lytic replication (oriLyt) are essential for ROCC. In contrast, its protein kinase and true late genes are not. We show that, unexpectedly, the viral lytic amplification is not required for chromatin compaction but is required for its margination. We propose a two-step model for ROCC: first, global chromatin compaction occurs as a cellular response to the initiation of viral DNA synthesis; then, the accumulation of newly synthesized, histone-free viral DNA leads to cellular chromatin margination. Taken together, our findings provide insights into a process contributing to the productive phase of five families of viruses. Five families of viruses support the reorganization of cellular chromatin (ROCC), the compaction and margination of host chromatin, upon their productive infection. That they all share this phenotype implies the importance of ROCC in viral life cycles.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] EPSTEIN-BARR VIRUS - RAVAGER
    PARULEKAR, SS
    RAPOPORT, A
    PAONESSA, DF
    KOUYOUMGIAN, J
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1978, 87 (05): : 729 - 735
  • [32] Epstein-Barr Virus and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (04) : 533 - 537
  • [33] Epstein-Barr virus reactivation
    Ternák, G
    LANCET INFECTIOUS DISEASES, 2003, 3 (05): : 271 - 271
  • [34] Epstein-Barr virus in tumours
    Anagnostopoulos, I
    Hummel, M
    HISTOPATHOLOGY, 1996, 29 (04) : 297 - 315
  • [35] INFECTION WITH EPSTEIN-BARR VIRUS
    DENMAN, AM
    SMITH, H
    BRITISH MEDICAL JOURNAL, 1979, 1 (6157): : 198 - 199
  • [36] THE EPSTEIN-BARR VIRUS PROTEINS
    DILLNER, J
    KALLIN, B
    ADVANCES IN CANCER RESEARCH, 1988, 50 : 95 - 158
  • [37] FOCUS ON EPSTEIN-BARR VIRUS
    CHARMOT, G
    GAZETTE MEDICALE DE FRANCE, 1983, 90 (28): : 2735 - 2737
  • [38] IMMUNOLOGY OF EPSTEIN-BARR VIRUS
    GUNVEN, P
    COMPREHENSIVE IMMUNOLOGY, 1982, 9 : 117 - 134
  • [39] Epstein-Barr virus and lymphomagenesis
    Rickinson, AB
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S388 - S388
  • [40] Epstein-Barr virus and cancer
    Thompson, MP
    Kurzrock, R
    CLINICAL CANCER RESEARCH, 2004, 10 (03) : 803 - 821